NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT01524094,Cytoreduction and Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Colorectal Peritoneal Carcinomatosis,https://clinicaltrials.gov/study/NCT01524094,,COMPLETED,The purpose of this study is to see if there is a difference in survival between two different treatment strategies for colorectal peritoneal surface disease. The control arm administered the currently considered standard treatment which is palliative systemic chemotherapy. The experimental arm received the combination treatment cytoreductive surgery and intraperitoneal chemotherapy. The investigators hypothesis is that the combination treatment will improve the overall survival.,NO,Colorectal Peritoneal Carcinomatosis,"DRUG: Systemic chemotherapy alone (oxaliplatin, 5-fluorouracil, isovorin)|PROCEDURE: Cytoreductive surgery (CRS) plus postoperative intraperitoneal chemotherapy (5-fluorouracil, isovorin)","Overall survival, 8 years","progression free survival, 8 years|Time to secondary treatment, 8 years|Radical resectability, 5 years|Quality of life, 7 years|Health costs, 8 years|Side effects of treatment, 6 years",,Uppsala University,,ALL,"ADULT, OLDER_ADULT",PHASE3,49,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,SPS-1,2003-06,2010-12,2012-01,2012-02-01,,2012-02-01,"Akademiska Sjukhuset (Uppsala University Hospital), Uppsala, SE-751 85, Sweden",
